Clinical Trials

Can Congress Improve Veterans’ Access to Non-VA Care?
Research & Development Can Congress Improve Veterans’ Access to Non-VA Care?

Picture a veteran, a Marine Corps and Army hero like John-Paul Sager, sitting in a small-town clinic just miles from home, yet unable to get treatment for chronic pain without wading through a swamp of paperwork and approvals. Across the nation, thousands of veterans face this reality, driving past

Trend Analysis: Flavonols in Drug Resistance Solutions
Research & Development Trend Analysis: Flavonols in Drug Resistance Solutions

In an era where medical advancements are constantly tested by evolving health challenges, drug resistance stands as a formidable barrier, impacting millions of patients worldwide with a staggering failure rate in treatments like chemotherapy, where up to 50% of cases show reduced efficacy due to

Can Miricorilant Revolutionize MASH Treatment in Trials?
Research & Development Can Miricorilant Revolutionize MASH Treatment in Trials?

In the realm of liver disease research, metabolic-associated steatohepatitis (MASH), a severe form of fatty liver disease also known as metabolic dysfunction-associated steatotic liver disease (MASLD), stands as a formidable challenge with potentially devastating consequences. Characterized by

FDA Fast Tracks Nektar’s Drug for Severe Alopecia Areata
Research & Development FDA Fast Tracks Nektar’s Drug for Severe Alopecia Areata

Imagine waking up each day to find more hair on your pillow than on your scalp, a stark reminder of an unseen battle within your body that strips away confidence. Alopecia areata (AA), an autoimmune condition, affects nearly 700,000 individuals in the United States, causing unpredictable hair loss

Why Did Praxis Stock Drop Despite Promising Epilepsy Drug Data?
Research & Development Why Did Praxis Stock Drop Despite Promising Epilepsy Drug Data?

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, particularly in the realm of innovative technologies for neurological disorders. Today, we’re diving into the recent clinical trial results from Praxis Precision Medicines

Can U.S. Organ Transplant Reforms Restore Public Trust?
Research & Development Can U.S. Organ Transplant Reforms Restore Public Trust?

In a nation where thousands of lives hang in the balance awaiting organ transplants, the U.S. system has long been plagued by systemic failures that have eroded public confidence. Reports of operational flaws, lack of accountability, and even shocking practices—such as initiating organ donation

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later